X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development

Particle Size Distribution Real-Time Monitoring With PEACE

Content Team by Content Team
10th May 2023
in Drug Development, News
Chinas Institute of Materia Medica Partners With Cyclica on Innovative Drug Repurposing for COVID-19

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Researchers have gone on to develop a physics-enhanced autocorrelation-based estimator (PEACE) machine learning algorithm that can go ahead with the extraction of the particle size distribution (PSD) of a pharmaceutical powder surface from its laser spot. The process provides a non-invasive, real-time, as well as a far-field optical probe so as to monitor particle size distribution in a quantitative way.

Forecasting the appearance of the large particles by way of consistent monitoring happens to be pivotal for process control, as per the research that got published in Nature Communications.

Electronic Speckle Pattern Interferometry (ESPI), notably, can go on to measure the motion distribution of the surface even at scales as tiny as a nanometre and is used to denote the roughness of the surface.

That said, extracting quantitative information when it comes to highly scattering surfaces from an imaging system is quite an uphill task, as per Zhang et al. This is due to the fact that the scattered light phase goes through multiple folds upon proliferation, thereby resulting in speckle patterns that happen to be complex.

Nevertheless, laser speckle pattern mostly functions only when the surface height fluctuation happens to be smaller than or is comparable to the light wavelength. This, therefore, curtails its application to the surfaces that are encountered in pharmaceutical manufacturing. Recent developments in machine learning have gone on to show imaging success via scattering media as well as suppression of the speckle. However, the speckle pattern is regarded as a disturbance that is unwanted.

According to Zhang et al., there happen to be no real-time monitoring approaches that can spot such particle size changes in the early stages and thereby safeguard such changes, which are abnormal for wet powder drying.
It is well to be noted that quantitative granularity characterization is indeed desirable when it comes to the powder drying process.

Although these parameters happen to be well controlled, the progression of the particle sizes during the process of agitation isn’t entirely predictable. Hence, it is of utmost essence to monitor particle sizes in real time, and that too quantitatively and correctly when it comes to abnormal size changes by way of feedback control in terms of process parameters like agitation, speed, and temperature.

Apparently, the free space multiplication equations helped the scientists relate the function pertaining to ensemble-averaged spatial integration autocorrelation to that of powder surface statistics like the particle size distribution.

One of the major advantages of this strategy happens to be its understandability. It is important to note that the inferences drawn from the activation map went on to be a complete match with the forward model that happens to be used by the researchers. The method goes on to solve both forward and inverse challenges all at once, as per the authors.

Especially in scenarios pertaining to densely concentrated wet powders, this method happens to be the first in-line measurement and is, as a matter of fact, easily deployable when it comes to the industrial instrument, making it apt for the processes related to blending as well as milling in the pharmaceutical manufacturing gamut.

Previous Post

Mettler-Toledo Showcases a Suite of Affordable Smart Inspection Technologies at Interpack to Boost Pharma Productivity

Next Post

Connected Drug Delivery Devices To Revolutionize Healthcare

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post

Connected Drug Delivery Devices To Revolutionize Healthcare

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In